{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:36:22Z","timestamp":1784637382883,"version":"3.55.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Iron deficiency anaemia (IDA) is a major health issues and common type of nutritional deficiency worldwide. For IDA treatment, intravenous (IV) iron is a useful therapy.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objective<\/jats:title>\n<jats:p>To determine the efficacy and cost-effectiveness (CE) of intravenous (IV) Ferric Carboxymaltose (FCM) versus IV Iron Sucrose (IS) in treating IDA.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Data sources<\/jats:title>\n<jats:p>Electronic medical record i.e. Cerner<jats:sup>\u00ae<\/jats:sup> system.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Target population<\/jats:title>\n<jats:p>Adults patients with iron deficiency anaemia.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Time horizon<\/jats:title>\n<jats:p>A 12-month period (01\/01\/2018\u201331\/12\/2018).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec006\">\n<jats:title>Perspective<\/jats:title>\n<jats:p>Hamad Medical Corporation (HMC, a public hospital).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec007\">\n<jats:title>Intervention<\/jats:title>\n<jats:p>IV Ferric Carboxymaltose versus IV Iron Sucrose.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec008\">\n<jats:title>Outcome measures<\/jats:title>\n<jats:p>With regard to responses to treatment i.e., efficacy of treatment with FCM &amp; IS in IDA patients, hemoglobin (Hgb), ferritin, and transferrin saturation (TSAT) levels were the primary outcomes. Additionally, the researchers also collected levels of iron, platelet, white blood cell (WBC), red blood cell (RBC), mean corpuscular hemoglobin (MCH), and mean corpuscular volume (MCV). The costs i.e. resources consumed (obtained from NCCCR-HMC) and the CE of FCM versus IS were the secondary outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec009\">\n<jats:title>Results of base-case analysis<\/jats:title>\n<jats:p>There was a significant improvement in Hgb, RBC and MCH levels in the IS group than the FCM group. The overall cost of IS therapy was significantly higher than FCM. The medication cost for FCM was approximately 6.5 times higher than IS, nonetheless, it is cheaper in terms of bed cost and nursing cost. The cost effectiveness (CE) ratio illustrated that FCM and IS were significantly different in terms of Hgb, ferritin and MCH levels. Further, Incremental Cost Effectiveness Ratio (ICER) indicated that further justifications and decisions need to be made for FCM when using Hgb, iron, TSAT, MCH and MCV levels as surrogate outcomes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec010\">\n<jats:title>Results of sensitivity analysis<\/jats:title>\n<jats:p>Not applicable.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec011\">\n<jats:title>Limitations<\/jats:title>\n<jats:p>The study did not consider the clinical or humanistic outcome.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec012\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The higher cost of FCM versus IS can be offset by savings in healthcare personnel time and bed space. ICER indicated that further justifications and decisions need to be made for FCM when using Hgb, iron, TSAT, MCH and MCV levels as surrogate outcomes.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0255104","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T17:24:02Z","timestamp":1628616242000},"page":"e0255104","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5171-1433","authenticated-orcid":true,"given":"Ahmad","family":"Basha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Izham Mohamed","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anas","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8291-7987","authenticated-orcid":true,"given":"Nabil E.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abdul Jaber","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood B.","family":"Aldapt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwa M.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6253-1670","authenticated-orcid":true,"given":"Ahmed","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad A.","family":"Adel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hawraa M.","family":"Shwaylia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaslem","family":"Ekeibed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"AbuMousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Yassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"pone.0255104.ref001","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0140-6736(10)62304-5","article-title":"Anaemia in lowincome and middle-income countries","volume":"Vol. 378","author":"Elsevier","year":"2011","journal-title":"The Lancet"},{"key":"pone.0255104.ref002","unstructured":"WHO\/ CDC. Worldwide prevalence of anaemia 1993\u20132005. WHO Global Database on Anaemia [Internet]. WHO Report. World Health Organization; 2008 [cited 2018 Dec 8]. 41 p. https:\/\/www.cabdirect.org\/cabdirect\/abstract\/20093013528"},{"key":"pone.0255104.ref003","unstructured":"WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Miner Nutr Inf Syst World Heal Organ [Internet]. 2011 [cited 2018 Dec 8];1\u20136. https:\/\/www.who.int\/vmnis\/indicators\/haemoglobin\/en\/"},{"key":"pone.0255104.ref004","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.mcna.2016.09.004","article-title":"Iron Deficiency Anemia","volume":"Vol. 101","author":"TG DeLoughery","year":"2017","journal-title":"Medical Clinics of North America"},{"issue":"2","key":"pone.0255104.ref005","first-page":"98","article-title":"Iron Deficiency Anemia: Evaluation and Management","volume":"87","author":"MW Short","year":"2013","journal-title":"Am Fam Physician"},{"key":"pone.0255104.ref006","article-title":"Intravenous vs. Oral Iron in Patients with Anemia","author":"PS Mueller","year":"2013","journal-title":"NEJM J Watch"},{"issue":"3","key":"pone.0255104.ref007","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1756283X11398736","article-title":"Diagnosis and management of iron deficiency anemia in the 21st century","volume":"4","author":"TD Johnson-Wimbley","year":"2011","journal-title":"Therap Adv Gastroenterol"},{"key":"pone.0255104.ref008","doi-asserted-by":"crossref","first-page":"169107","DOI":"10.1155\/2013\/169107","article-title":"Direct comparison of the safety and efficacy of Ferric carboxymaltose versus iron dextran in patients with iron deficiency anemia","volume":"2013","author":"I Hussain","year":"2013","journal-title":"Anemia"},{"issue":"06","key":"pone.0255104.ref009","first-page":"386","article-title":"Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications. Arzneimittelforschung","volume":"60","author":"G Bailie","year":"2011"},{"issue":"10","key":"pone.0255104.ref010","first-page":"846","article-title":"A Cost-effectiveness Analysis of Ferric Carboxymaltose in Patients With Iron Deficiency and Chronic Heart Failure in Spain","volume":"68","author":"J Com\u00edn-Colet","year":"2015","journal-title":"Rev Esp Cardiol"},{"issue":"9","key":"pone.0255104.ref011","doi-asserted-by":"crossref","first-page":"A634","DOI":"10.1016\/j.jval.2017.08.1437","article-title":"Cost-Effectiveness of Ferric Carboxymaltose (FCM) in the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease (IBD)","volume":"20","author":"E Walter","year":"2017","journal-title":"Value Heal"},{"issue":"1","key":"pone.0255104.ref012","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/2229-516X.149230","article-title":"Ferric carboxymaltose: A revolution in the treatment of postpartum anemia in Indian women","volume":"5","author":"S Rathod","year":"2015","journal-title":"Int J Appl Basic Med Res"},{"issue":"5","key":"pone.0255104.ref013","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1515\/jpm-2011-0231","article-title":"Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose","volume":"40","author":"P Christoph","year":"2012","journal-title":"J Perinat Med"},{"key":"pone.0255104.ref014","unstructured":"Health Decision Strategies, LLC. http:\/\/www.healthstrategy.com\/cgi-bin\/formularycea01.pl"},{"key":"pone.0255104.ref015","unstructured":"Incremental Cost-Effectiveness Ratio (ICER) [online]. (2016). York; York Health Economics Consortium; 2016. https:\/\/yhec.co.uk\/glossary\/incremental-cost-effectiveness-ratio-icer\/"},{"key":"pone.0255104.ref016","volume-title":"Peginterferon Alfa and Ribavirin for Chronic Hepatitis C in Patients Eligible for Shortened Treatment, Re-Treatment or in HCV\/HIV Co-Infection: A Systematic Review and Economic Evaluation","author":"D Hartwell"},{"issue":"1","key":"pone.0255104.ref017","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12884-019-2200-3","article-title":"Comparison of ferric Carboxymaltose and iron sucrose complex for treatment of iron deficiency anemia in pregnancy- randomised controlled trial","volume":"19","author":"A Jose","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"pone.0255104.ref018","volume-title":"The global prevalence of anaemia in 2011","author":"WHO","year":"2015"},{"key":"pone.0255104.ref019","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4172\/2167-7182.1000421","article-title":"Prevalence and Impact of Anemia Among Elderly Population in Qatar: A Cross Sectional Study","volume":"6","author":"MA Obaidely","year":"2017","journal-title":"J Gerontol Geriatr Res"},{"key":"pone.0255104.ref020","doi-asserted-by":"crossref","first-page":"e020271","DOI":"10.1136\/bmjopen-2017-020271","article-title":"Iron deficiency, its epidemiological features and feeding practices among infants aged 12 months in Qatar: a cross-sectional study","volume":"8","author":"AJAL Zainel","year":"2018","journal-title":"BMJ Open"},{"key":"pone.0255104.ref021","article-title":"Comparative Efficacy of Three Forms of Parenteral Iron","author":"R Dillon","year":"2012","journal-title":"Journal of Blood Transfusion"},{"key":"pone.0255104.ref022","article-title":"Oral high-dose sucrosomial iron vs intravenous iron in sideropenic anemia patients intolerant\/refractory to iron sulfate: a multicentric randomized study","author":"G. Giordano","year":"2020","journal-title":"Ann Hematol"},{"key":"pone.0255104.ref023","article-title":"Comparative efficacy and safety of intravenous ferric carboxymaltose and iron sucrose for the treatment of preoperative anemia in patients with menorrhagia: An open-label, multicenter, randomized study","author":"S Lee","year":"2019","journal-title":"The Journal of Obstetric and Gynaecology Research"},{"issue":"6","key":"pone.0255104.ref024","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2165\/00003495-200969060-00007","article-title":"Ferric carboxymaltose: a review of its use in iron-deficiency anaemia","volume":"69","author":"KA Lyseng-Williamson","year":"2009","journal-title":"Drugs"},{"issue":"1","key":"pone.0255104.ref025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/1756283X15616577","article-title":"The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease","volume":"9","author":"P Koduru","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"issue":"6","key":"pone.0255104.ref026","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bjhh.2015.08.012","article-title":"Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia","volume":"37","author":"JR Friedrisch","year":"2015","journal-title":"Revista Brasileira de Hematologia e Hemoterapia"},{"key":"pone.0255104.ref027","first-page":"127","article-title":"Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece","volume":"4","author":"V Fragoulakis","year":"2012","journal-title":"Clinicoecon Outcomes Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0255104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T17:24:28Z","timestamp":1628616268000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0255104"}},"subtitle":[],"editor":[{"given":"Pavel","family":"Strnad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0255104","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]}}}